F. Hoffmann-La Roche
CEP Certificates (EDQM COS List)

F. Hoffmann-La Roche

CEP Database

Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.

Chemical Switzerland
  • Total Records 7
  • Latest End Date 2018-05-24
  • Data Source EDQM
  • Last Updated 2015-09-24
All
7
View
Valid
5
View
Withdrawn
2
View
Company Overview

Company

F. Hoffmann-La Roche

Country

Switzerland

Social Profiles

Company Snapshot

F. Hoffmann-La Roche

Konzern-Hauptsitz Grenzacherstrasse 124 CH-4070 Basel

Switzerland

www.roche.com/ rocheirna@gene.com View on Map
CEP Records Timeline (7 records)
2015
24 Sep
Chemical Valid

Product

Sulfadoxine

Substance

F Hoffmann-La Roche Ltd. Basel CH

Certificate No.

R1-CEP 2000-066 - Rev 04

Substance No.

740

Issue Date

2015-09-24

End Date

-

Switzerland

Country

Switzerland

Identifiers

Certificate No.: R1-CEP 2000-066 - Rev 04
Substance No.: 740

2012
25 Jul
Chemical Valid

Product

Carvedilol

Substance

F Hoffmann-La Roche Ltd. Basel CH

Certificate No.

R1-CEP 2002-001 - Rev 03

Substance No.

1745

Issue Date

2012-07-25

End Date

-

Switzerland

Country

Switzerland

Identifiers

Certificate No.: R1-CEP 2002-001 - Rev 03
Substance No.: 1745

2011
30 Sep
Chemical Valid

Product

Torasemide

Substance

F Hoffmann-La Roche Ltd. Basel CH

Certificate No.

R1-CEP 2005-210 - Rev 00

Substance No.

2132

Issue Date

2011-09-30

End Date

-

Switzerland

Country

Switzerland

Identifiers

Certificate No.: R1-CEP 2005-210 - Rev 00
Substance No.: 2132

2010
26 Nov
Chemical Valid

Product

Bezafibrate

Substance

F Hoffmann-La Roche Ltd. Basel CH

Certificate No.

R1-CEP 1998-124 - Rev 04

Substance No.

1394

Issue Date

2010-11-26

End Date

-

Switzerland

Country

Switzerland

Identifiers

Certificate No.: R1-CEP 1998-124 - Rev 04
Substance No.: 1394

2009
19 Nov
Chemical Withdrawn by Holder

Product

Glibenclamide

Substance

F Hoffmann-La Roche Ltd. Basel CH

Certificate No.

R1-CEP 1999-003 - Rev 01

Substance No.

718

Issue Date

2009-11-19

End Date

2015-07-01

Switzerland

Country

Switzerland

Identifiers

Certificate No.: R1-CEP 1999-003 - Rev 01
Substance No.: 718

2008
25 Nov
Chemical Withdrawn by Holder

Product

Isotretinoin

Substance

F Hoffmann-La Roche Ltd. Basel CH

Certificate No.

R1-CEP 2002-034 - Rev 01

Substance No.

1019

Issue Date

2008-11-25

End Date

2018-05-24

Switzerland

Country

Switzerland

Identifiers

Certificate No.: R1-CEP 2002-034 - Rev 01
Substance No.: 1019

2008
06 May
Chemical Valid

Product

Ceftriaxone sodium, Sterile

Substance

F Hoffmann-La Roche Ltd. Basel CH

Certificate No.

R1-CEP 2001-084 - Rev 01

Substance No.

991

Issue Date

2008-05-06

End Date

-

Switzerland

Country

Switzerland

Identifiers

Certificate No.: R1-CEP 2001-084 - Rev 01
Substance No.: 991

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    7 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
Status Breakdown
7 total
  • Valid
  • Withdrawn by holder
Official Source

All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).

Visit EDQM
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Country

Switzerland

Identifiers

Certificate No.: R1-CEP 2000-066 - Rev 04
Substance No.: 740

100% Official Data

Directly from the EDQM CEP database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

CEP data is obtained from the official EDQM (European Directorate for the Quality of Medicines) database.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.